Administrative and Bioinformatics Core
行政和生物信息学核心
基本信息
- 批准号:8768692
- 负责人:
- 金额:$ 28.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AccountabilityAdherenceAdhesivesAnusAreaBioinformaticsClinicalCollaborationsCollectionCommittee MembershipCommunicationCommunitiesDataData ReportingDatabase Management SystemsDevelopmentDevelopment PlansDocumentationDoseEarly DiagnosisEducationEnsureEthicsFinancial SupportFosteringFoundationsGoalsGroup MeetingsHIVHIV InfectionsHealth Insurance Portability and Accountability ActHuman ResourcesInformaticsInternetLeadershipLearningLibrariesLinkMaintenanceManagement AuditMonitorNational Institute of Allergy and Infectious DiseasePlayPoliciesPreventionPrincipal InvestigatorProcessProdrugsProgress ReportsPublicationsRecurrenceReportingResearch InfrastructureResourcesRoleRunningSiteStrategic PlanningStructureSystemTeleconferencesTenofovirTimeTimeLineUnited States National Institutes of HealthUpdateabstractingbiomedical informaticsdata managementenema administrationexperienceflexibilityinterestmeetingsmicrobicideoperationpre-clinicalprogramsprospectiverectalrectal microbiciderepositorysymposiumweb site
项目摘要
The Administrative Core (Core A) will direct and coordinate several major areas contributing to the activities of
the Development of Rectal Enema as Microbicide (DREAM) Program whose overall goal it is to develop a
single dose tenofovir prodrug enema to provide one week of protection from HIV infection following
unprotected receptive anal intercourse. These activities include (1) administrative oversight of the entire
program including all Projects and Cores, (2) providing financial oversight of the program, (3) act as primary
liaison with the NIAID/DAIDS appointed Program Officer with responsibility for the Integrated
Preclinical/Clinical Program for HIV Microbicides and Biomedical Prevention U19 Program, (4) coordinate the
monthly conference calls for the Steering Committee (SC) and disseminate agendas / meeting minutes in a
timely fashion, (5) organize the annual IP/CP meeting, (5) in collaboration with NIAID/DAIDS, establish and
provide logistical support for a Scientific Advisory Panel facilitation, and (6) undertake website maintenance,
education, publication assistance, library maintenance, and general administrative support. The Core will link
the various project leaders and programs as well as integrate the related milestones of each project and
ensuring communication between project leaders. The SC, composed of the Principal Investigator and each
Project Leader/Associate-Leader, Core Leader/Associate Leader, and select key personnel, will be the central
mechanism in assuring communication between Projects, Project sites, and Cores. The Administrative Core
will also produce twice-yearly internal progress reports for the SC. These will be available to interested key
personnel and the NIH's Scientific Advisory Panel (SAP).
行政核心(核心A)将指导和协调促进以下活动的几个主要领域
直肠灌肠作为杀微生物剂的发展(梦想)计划,其总体目标是开发一种
单剂量替诺福韦前体药物灌肠剂提供一周的保护,从艾滋病毒感染后,
无保护的肛交这些活动包括:(1)对整个
计划,包括所有项目和核心,(2)提供计划的财务监督,(3)作为主要的
与NIAID/DAIDS任命的负责综合
HIV杀微生物剂和生物医学预防U19计划的临床前/临床计划,(4)协调
每月召开指导委员会(SC)会议,并以
及时,(5)组织年度IP/CP会议,(5)与NIAID/DAIDS合作,
为科学咨询小组提供后勤支持,以及(6)进行网站维护,
教育、出版援助、图书馆维护和一般行政支助。核心将连接
各种项目负责人和项目,并整合每个项目的相关里程碑,
确保项目负责人之间的沟通。SC由主要研究者组成,
项目负责人/副负责人、核心负责人/副负责人和选定的关键人员将是
确保项目、项目地点和核心之间沟通的机制。行政核心
每年还将为SC编写两次内部进度报告。这些报告将提供给感兴趣的关键
NIH的科学顾问小组(SAP)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter A Anton其他文献
The Other Compartment: Challenges and Progress in Rectal Microbicide Development
- DOI:
10.1186/1742-4690-2-s1-s89 - 发表时间:
2005-12-08 - 期刊:
- 影响因子:3.900
- 作者:
Peter A Anton - 通讯作者:
Peter A Anton
Peter A Anton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter A Anton', 18)}}的其他基金
Topical Microbicides: Targeted Intracellular Delivery
局部杀菌剂:靶向细胞内递送
- 批准号:
8810224 - 财政年份:2014
- 资助金额:
$ 28.51万 - 项目类别:
Topical Microbicides: Targeted Intracellular Delivery
局部杀菌剂:靶向细胞内递送
- 批准号:
8711813 - 财政年份:2014
- 资助金额:
$ 28.51万 - 项目类别:
Mechanistic Studies of HIV-exposed Seronegative Individuals
HIV 血清阴性个体的机制研究
- 批准号:
8503631 - 财政年份:2012
- 资助金额:
$ 28.51万 - 项目类别:
Exploratory human trials of rectal microbicides
直肠杀菌剂的探索性人体试验
- 批准号:
7979345 - 财政年份:2009
- 资助金额:
$ 28.51万 - 项目类别:
Regulatory compliance and human subjects safety
法规遵从性和人体受试者安全
- 批准号:
7979340 - 财政年份:2009
- 资助金额:
$ 28.51万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
Fellowship Programs